CY1111436T1 - Πολυστρωματικο συστημα χορηγησης φαρμακων με φραγμα εναντια στη ροη του υλικου ταμιευτηρα - Google Patents
Πολυστρωματικο συστημα χορηγησης φαρμακων με φραγμα εναντια στη ροη του υλικου ταμιευτηραInfo
- Publication number
- CY1111436T1 CY1111436T1 CY20101101082T CY101101082T CY1111436T1 CY 1111436 T1 CY1111436 T1 CY 1111436T1 CY 20101101082 T CY20101101082 T CY 20101101082T CY 101101082 T CY101101082 T CY 101101082T CY 1111436 T1 CY1111436 T1 CY 1111436T1
- Authority
- CY
- Cyprus
- Prior art keywords
- medicamental
- laminated
- fluid flow
- system supply
- medicinal fluid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0203—Adhesive plasters or dressings having a fluid handling member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
- A61F2013/0296—Apparatus or processes for manufacturing adhesive dressings or bandages for making transdermal patches (chemical processes excluded)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
- Y10T156/10—Methods of surface bonding and/or assembly therefor
- Y10T156/1052—Methods of surface bonding and/or assembly therefor with cutting, punching, tearing or severing
- Y10T156/1082—Partial cutting bonded sandwich [e.g., grooving or incising]
Abstract
Ένα πολυστρωματικό σύστημα χορήγησης φαρμάκων με ένα φράγμα κατάλληλλο για την χορήγηση των φαρμάκων μέσω της επιφάνειας του σώματος ενός ατόμου. Με την τοποθέτηση ενός φράγματος μεταξύ δύο παρακείμενων στρωμάτων αποφεύγεται η ακούσια ροή των φαρμάκων, λόγω της μεταρροής του ενός φαρμάκου της μήτρας (περίβλημα) μεταξύ των παρακείμενων στρωμάτων η μήτρα (περίβλημα) του συστήματος σε έναν ασθενή.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68090505P | 2005-05-13 | 2005-05-13 | |
US79023606P | 2006-04-07 | 2006-04-07 | |
EP06759664A EP1895994B1 (en) | 2005-05-13 | 2006-05-12 | Multilayer drug delivery system with barrier against reservoir material flow |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1111436T1 true CY1111436T1 (el) | 2015-08-05 |
Family
ID=36928681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20101101082T CY1111436T1 (el) | 2005-05-13 | 2010-11-25 | Πολυστρωματικο συστημα χορηγησης φαρμακων με φραγμα εναντια στη ροη του υλικου ταμιευτηρα |
Country Status (10)
Country | Link |
---|---|
US (3) | US8632800B2 (el) |
EP (3) | EP1895994B1 (el) |
AT (1) | ATE478659T1 (el) |
CY (1) | CY1111436T1 (el) |
DE (1) | DE602006016441D1 (el) |
DK (1) | DK1895994T3 (el) |
HK (1) | HK1157244A1 (el) |
PL (1) | PL1895994T3 (el) |
PT (1) | PT1895994E (el) |
WO (2) | WO2006124584A2 (el) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1895994T3 (pl) * | 2005-05-13 | 2011-02-28 | Alza Corp | Wielowarstwowy system podawania leków z barierą zabezpieczającą przed wypływaniem materiału ze zbiornika |
US8383149B2 (en) * | 2005-09-23 | 2013-02-26 | Alza Corporation | High enhancer-loading polyacrylate formulation for transdermal applications |
WO2007035941A2 (en) * | 2005-09-23 | 2007-03-29 | Alza Corporation | Transdermal galantamine delivery system |
US20080226698A1 (en) * | 2007-03-16 | 2008-09-18 | Mylan Technologies, Inc. | Amorphous drug transdermal systems, manufacturing methods, and stabilization |
ES2692437T3 (es) * | 2007-08-13 | 2018-12-03 | Abuse Deterrent Pharmaceutical Llc | Fármacos resistentes al abuso, método de uso y método de preparación |
WO2010042152A2 (en) * | 2008-10-06 | 2010-04-15 | Mylan Technologies, Inc. | Amorphous rotigotine transdermal system |
KR101317158B1 (ko) * | 2011-02-18 | 2013-10-15 | 조선대학교산학협력단 | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 |
ES2851175T3 (es) | 2013-02-05 | 2021-09-03 | Purdue Pharma Lp | Formulaciones farmacéuticas resistentes a manipulación |
WO2015021031A1 (en) | 2013-08-05 | 2015-02-12 | Cam Med Llc | Conformable patch pump |
KR101485822B1 (ko) * | 2014-01-22 | 2015-01-23 | 주식회사 대웅제약 | 도네페질 또는 그의 염을 함유하는 경피흡수제제 |
US10449201B2 (en) * | 2015-08-17 | 2019-10-22 | Alpha To Omega Pharmaceutical Consultants, Inc. | Transdermal and/or topical delivery system comprising clobazam |
DE102018216244A1 (de) * | 2018-09-24 | 2020-03-26 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit Barriereschicht |
ES2936735B2 (es) * | 2021-09-20 | 2023-11-29 | Paterna Jesus Paterna | Dispositivo para preparar manualmente sistemas terapéuticos transdérmicos y procedimiento |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3493657A (en) | 1961-03-14 | 1970-02-03 | Mozes Juda Lewenstein | Therapeutic compositions of n-allyl-14-hydroxy - dihydronormorphinane and morphine |
US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3598122A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3773955A (en) | 1970-08-03 | 1973-11-20 | Bristol Myers Co | Analgetic compositions |
GB1451994A (en) * | 1973-07-20 | 1976-10-06 | Smithe Machine Co Inc F L | Method and apparatus for cutting and applying patches |
US4214557A (en) * | 1978-08-15 | 1980-07-29 | Beach Corbett D Jr | Pivoting wall type, four stroke, internal combustion, rotary engine |
US4457933A (en) | 1980-01-24 | 1984-07-03 | Bristol-Myers Company | Prevention of analgesic abuse |
US4286592A (en) | 1980-02-04 | 1981-09-01 | Alza Corporation | Therapeutic system for administering drugs to the skin |
US4314557A (en) | 1980-05-19 | 1982-02-09 | Alza Corporation | Dissolution controlled active agent dispenser |
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
US4464378A (en) | 1981-04-28 | 1984-08-07 | University Of Kentucky Research Foundation | Method of administering narcotic antagonists and analgesics and novel dosage forms containing same |
US4588580B2 (en) | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
US4626539A (en) | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
US4568343A (en) * | 1984-10-09 | 1986-02-04 | Alza Corporation | Skin permeation enhancer compositions |
US4806341A (en) | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
US5538736A (en) * | 1987-04-28 | 1996-07-23 | Lts Lohmann Therapie-Systeme Gmbh | Active substance-containing plaster for the controlled administration of active substances to the skin |
US4983395A (en) * | 1987-11-12 | 1991-01-08 | Theratech Inc. | Device for administering an active agent to the skin or mucosa |
US4849224A (en) * | 1987-11-12 | 1989-07-18 | Theratech Inc. | Device for administering an active agent to the skin or mucosa |
GB8728294D0 (en) | 1987-12-03 | 1988-01-06 | Reckitt & Colmann Prod Ltd | Treatment compositions |
US5236714A (en) | 1988-11-01 | 1993-08-17 | Alza Corporation | Abusable substance dosage form having reduced abuse potential |
US5350581A (en) * | 1989-12-14 | 1994-09-27 | Pharmetrix Corporation | Method for manufacturing transdermal devices |
DE4010079A1 (de) | 1990-03-29 | 1991-10-02 | Lohmann Therapie Syst Lts | Pharmazeutische formulierung zur behandlung des alkoholismus |
US5149538A (en) | 1991-06-14 | 1992-09-22 | Warner-Lambert Company | Misuse-resistive transdermal opioid dosage form |
KR950701516A (ko) * | 1992-05-13 | 1995-04-28 | 에드워드 엘. 만델 | 옥시부티닌의 경피 투여(Transdermal Administration of Oxybutynin) |
DE4301783C1 (de) | 1993-01-23 | 1994-02-03 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil |
US6316439B1 (en) | 1993-10-15 | 2001-11-13 | Aventis Pharamaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US6323195B1 (en) * | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US6323196B1 (en) | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
DE19509663A1 (de) | 1995-03-17 | 1996-09-19 | Lohmann Therapie Syst Lts | Verfahren zur Isolierung von Galanthamin |
DE69614841T2 (de) * | 1995-04-06 | 2002-04-11 | Janssen Pharmaceutica Nv | Verfahren zur Herstellung von Galanthaminderivate durch asymmetrische Reduktion |
US5882676A (en) | 1995-05-26 | 1999-03-16 | Alza Corporation | Skin permeation enhancer compositions using acyl lactylates |
US5785991A (en) | 1995-06-07 | 1998-07-28 | Alza Corporation | Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate |
US5693335A (en) | 1995-06-07 | 1997-12-02 | Cygnus, Inc. | Skin permeation enhancer composition for use with sex steroids |
GB9514821D0 (en) | 1995-07-19 | 1995-09-20 | Sod Conseils Rech Applic | Galanthamine derivatives |
GB9519268D0 (en) * | 1995-09-21 | 1995-11-22 | Chiroscience Ltd | Preparation of alkaloids |
GB9519267D0 (en) * | 1995-09-21 | 1995-11-22 | Chiroscience Ltd | Preparation of alkaloids |
EP0934078B1 (en) | 1996-10-24 | 2002-12-18 | Alza Corporation | Permeation enhancers for transdermal drug delivery compositions, devices, and methods |
SI1299104T1 (sl) | 2000-02-08 | 2009-10-31 | Euro Celtique Sa | Oralne formulacije opioidnih agonistov, varne pred zlorabo |
CN100508974C (zh) | 2001-03-16 | 2009-07-08 | 阿尔扎公司 | 施用芬太尼的经皮贴剂 |
WO2002087482A1 (en) | 2001-05-01 | 2002-11-07 | Euro-Celtique | Abuse resistant opioid containing transdermal systems |
FR2826005B1 (fr) | 2001-06-15 | 2004-07-16 | Centre Nat Rech Scient | Synthese totale de la galanthamine, de ses analogues et de ses derives |
DE10129265A1 (de) * | 2001-06-18 | 2003-01-02 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie |
US8440220B2 (en) * | 2002-04-23 | 2013-05-14 | Durect Corporation | Transdermal analgesic systems with reduced abuse potential |
US8524272B2 (en) * | 2003-08-15 | 2013-09-03 | Mylan Technologies, Inc. | Transdermal patch incorporating active agent migration barrier layer |
EP1898891A2 (en) | 2005-05-13 | 2008-03-19 | Alza Corporation | Multilayer drug delivery system with barrier against antagonist exposure |
PL1895994T3 (pl) | 2005-05-13 | 2011-02-28 | Alza Corp | Wielowarstwowy system podawania leków z barierą zabezpieczającą przed wypływaniem materiału ze zbiornika |
-
2006
- 2006-05-12 PL PL06759664T patent/PL1895994T3/pl unknown
- 2006-05-12 EP EP06759664A patent/EP1895994B1/en active Active
- 2006-05-12 EP EP10006699.2A patent/EP2316437B1/en not_active Not-in-force
- 2006-05-12 DE DE602006016441T patent/DE602006016441D1/de active Active
- 2006-05-12 DK DK06759664.3T patent/DK1895994T3/da active
- 2006-05-12 EP EP06759665A patent/EP1895995A2/en not_active Withdrawn
- 2006-05-12 US US11/433,343 patent/US8632800B2/en not_active Expired - Fee Related
- 2006-05-12 WO PCT/US2006/018426 patent/WO2006124584A2/en active Application Filing
- 2006-05-12 PT PT06759664T patent/PT1895994E/pt unknown
- 2006-05-12 AT AT06759664T patent/ATE478659T1/de active
- 2006-05-12 WO PCT/US2006/018427 patent/WO2006124585A2/en active Application Filing
- 2006-05-12 US US11/432,918 patent/US20060257461A1/en not_active Abandoned
-
2010
- 2010-11-25 CY CY20101101082T patent/CY1111436T1/el unknown
-
2011
- 2011-11-02 HK HK11111814.8A patent/HK1157244A1/xx not_active IP Right Cessation
-
2014
- 2014-01-21 US US14/160,416 patent/US20140130973A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PL1895994T3 (pl) | 2011-02-28 |
US20060257462A1 (en) | 2006-11-16 |
DK1895994T3 (da) | 2010-12-20 |
HK1157244A1 (en) | 2012-06-29 |
DE602006016441D1 (de) | 2010-10-07 |
EP2316437A1 (en) | 2011-05-04 |
US20140130973A1 (en) | 2014-05-15 |
US20060257461A1 (en) | 2006-11-16 |
PT1895994E (pt) | 2010-12-03 |
EP1895994A2 (en) | 2008-03-12 |
WO2006124584A3 (en) | 2007-04-19 |
EP1895994B1 (en) | 2010-08-25 |
WO2006124585A2 (en) | 2006-11-23 |
US8632800B2 (en) | 2014-01-21 |
WO2006124585A3 (en) | 2007-05-03 |
ATE478659T1 (de) | 2010-09-15 |
EP1895995A2 (en) | 2008-03-12 |
EP2316437B1 (en) | 2014-07-30 |
WO2006124584A2 (en) | 2006-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111436T1 (el) | Πολυστρωματικο συστημα χορηγησης φαρμακων με φραγμα εναντια στη ροη του υλικου ταμιευτηρα | |
WO2006124749A3 (en) | Multilayer drug delivery system with barrier against antagonist exposure | |
WO2010042471A3 (en) | Medical devices for delivery of therapeutic agents to body lumens | |
BRPI0514834B8 (pt) | processo de montagem de dispositivos de envio de fármaco e dispositivo de envio de fármaco | |
WO2009045784A3 (en) | Disposable infusion device layered structure | |
WO2011049744A3 (en) | Microclimate management system | |
WO2007115039A3 (en) | Multi-cartridge fluid delivery device | |
WO2007108970A3 (en) | Infusion device with piston pump | |
WO2010029551A3 (en) | Methods and devices for tailoring a bolus delivery pattern | |
ATE419842T1 (de) | Abgabevehikel mit nanoteilchen | |
SMAP200900075A (it) | Dispositivi terapeutici ibridi impiantabili | |
ATE550053T1 (de) | Laminierte patienteninfusionsvorrichtung | |
AR063958A1 (es) | Metodos para administrar medicaciones para la perdida de peso | |
WO2006133101A3 (en) | Agent delivery system | |
ECSP088709A (es) | Dispositivo de inyeccion con un sensor capacitivo de proximidad | |
DE602005009121D1 (de) | Keramischer Verbundkörper mit intergrierter nachgiebiger Verschleissschicht | |
ES2571854T3 (es) | Dispositivo de suministro montable en superficie | |
GB2464902A (en) | Needle array assembly and method for delivering therapeutic agents | |
EP1827932A4 (en) | LIQUID DISPENSING SYSTEM COMPRISING A LIQUID CIRCUIT PROVIDED WITH A STERILE RETAINING VALVE CONNECTOR | |
DE602005027059D1 (de) | Polymer-füllstoff-komposite für die kontrollierte abgabe von therapeutischen mitteln aus medizinischen artikeln | |
HK1142270A1 (en) | Silibinin component for the treatment of hepatitis | |
CL2014001478A1 (es) | Pelicula de capas multiples libre de capa metalica, que comprende una capa exterior de al menos un polimero de olefina termoplastica, capa de agente de adherencia, capa de al menos una poliamida, capa de barrera de gas, capa de poliamida, adyacente a la anterior, y capa exterior de poliamida; uso; cuerpo ascencional; y globo. | |
BR112015026668A2 (pt) | auxílio de fluxo para estrutura de infusão, estrutura de infusão com auxílio de fluxo, bem como método para a infiltração de material de fibra com resina | |
ECSP099828A (es) | Uso de ranolazina para peptido natriuretico tipo-cerebral elevado | |
CL2008003133A1 (es) | Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa. |